Institutional investors purchased a net $5.7 million shares of SYK during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 70.24% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
| Other institutional | 38.71% |
| Mutual fund holders | 31.53% |
| Individual stakeholders | 25.64% |